JPMorgan Chase & Co’s Landos Biopharma, Inc. Common Stock LABP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-59
| Closed | -$1.27K | – | 6694 |
|
|
2024
Q1 | $1.27K | Hold |
59
| – | – | ﹤0.01% | 5611 |
|
|
2023
Q4 | $216 | Hold |
59
| – | – | ﹤0.01% | 6001 |
|
|
2023
Q3 | $228 | Hold |
59
| – | – | ﹤0.01% | 5870 |
|
|
2023
Q2 | $247 | Sell |
59
-2
| -3% | -$8 | ﹤0.01% | 5707 |
|
|
2023
Q1 | $0 | Hold |
61
| – | – | ﹤0.01% | 6282 |
|
|
2022
Q4 | $0 | Sell |
61
-163
| -73% | – | ﹤0.01% | 6141 |
|
|
2022
Q3 | $1K | Buy |
224
+51
| +29% | +$228 | ﹤0.01% | 5481 |
|
|
2022
Q2 | $1K | Sell |
173
-29,065
| -99% | -$168K | ﹤0.01% | 5541 |
|
|
2022
Q1 | $432K | Sell |
29,238
-724
| -2% | -$10.7K | ﹤0.01% | 4084 |
|
|
2021
Q4 | $1.44M | Sell |
29,962
-1,037
| -3% | -$49.8K | ﹤0.01% | 3443 |
|
|
2021
Q3 | $4.53M | Sell |
30,999
-6,484
| -17% | -$947K | ﹤0.01% | 2652 |
|
|
2021
Q2 | $4.33M | Sell |
37,483
-19
| -0.1% | -$2.19K | ﹤0.01% | 2739 |
|
|
2021
Q1 | $3.61M | Buy |
+37,502
| New | +$3.61M | ﹤0.01% | 2865 |
|